The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Multiple strategies are employed maximize antibody titer, including process parameter optimization, media optimization, and implementation of perfusion technologies. Fine-tuning culture condition